Experienced Healthcare Leader to Drive Strategic Growth and Innovation
FRANKLIN, Tenn., May 23, 2024 -- Azra AI, a healthtech leader harnessing artificial intelligence (AI) and workflow automation to accelerate the identification and treatment of cancer, is excited to announce the promotion of Brook Blackmore from Vice President of Clinical Operations to Chief Strategy Officer (CSO). This strategic move underscores Azra AI's dedication to leveraging Blackmore's extensive clinical expertise and deep understanding of customer needs to steer the company’s growth and innovation.
Brook Blackmore, a seasoned healthcare executive, has been instrumental in shaping Azra AI’s clinical strategy since joining the company. Her extensive experience in oncology operations and her familiarity with Azra AI's proprietary technology, developed during her tenure at Sarah Cannon, the cancer institute of HCA Healthcare, uniquely position her to lead the company’s strategic vision.
Driving Innovation in Oncology Care
In her new role as CSO, Blackmore will focus on expanding the reach of Azra AI's enterprise platform, which provides the only end-to-end SaaS solution across the entire cancer patient journey—from suspicion through survivorship. This promotion comes at a pivotal time for Azra AI as the company experiences increased demand for its innovative solutions that address pressing challenges in the healthcare sector, including staffing shortages, burnout, razor-thin margins, and operational inefficiencies.
"Brook has been a driving force in the market traction we are receiving by consistently showcasing her ability to blend clinical expertise with strategic vision. Her ability to connect and work closely with customers at a deep clinical level, but also showing how Azra brings a true ROI to oncology service lines, has been absolutely remarkable. Elevating her to Chief Strategy Officer is a natural progression that will undoubtedly propel Azra AI to new heights," said John Marshall, CEO of Azra AI. "Her intimate knowledge of our technology and the needs of our clients positions her perfectly to lead our strategic initiatives."
A Vision for the Future
"This promotion reflects the incredible work our team has accomplished together. I am eager to further our mission of transforming oncology care through innovative AI solutions," said Blackmore. "Our technology not only enhances clinical workflows but also significantly improves patient outcomes and health equity. I look forward to driving strategic initiatives that will continue to make a meaningful difference in the lives of patients and healthcare providers."
Additional Resources
- Watch Azra AI’s full webinar titled “Harnessing AI for Oncology Service Line Excellence” moderated by Brook Blackmore, RN, MSN, MBA with guest panelists Dr. Douglas Flora from St. Elizabeth Healthcare and Jami DeNigris from Inspira Health.
- Schedule a demo with our experts at www.azra-ai.com/get-a-demo.
- Stay at the forefront of healthtech innovation and insights by following Azra AI on LinkedIn for exciting updates and thought-provoking content.
About Brook Blackmore
Brook Blackmore holds a master's degree in nursing from Tennessee State University and a bachelor's degree in nursing from Belmont University in Nashville. She also earned a master's degree in business administration with a focus in healthcare from Western Governors University. Her background as a nurse practitioner and registered nurse in oncology has provided her with a comprehensive understanding of patient care and clinical operations.
About Azra AI
Azra AI is a healthtech firm that leverages advanced AI and machine learning to automate oncology workflows. Its proven SaaS enterprise platform is used by more than 200 hospitals and cancer centers across the country to identify positive cancer diagnoses and incidental findings in real-time, classify by primary site, and route those patients to cancer navigators and other staff to immediately start the cancer care journey. The results include faster time to treatment, increased navigator time with patients, and better oncology patient retention. Additionally, the solution delivers dramatic operational and financial gains through intelligent automation.
